myelopeptide 1 has been researched along with Tuberculosis, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Averchenkov, VM; Fedotova, NI; Lomachenkov, VD; Meshkova, RIa | 1 |
| Kurbanova, RR; Stepanenko, RN; Ubaĭdullaev, AM; Vakhidova, GA; Vasil'eva, FR | 1 |
2 other study(ies) available for myelopeptide 1 and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
[Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
Topics: Activins; Adjuvants, Immunologic; Adult; Antitubercular Agents; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunologic Deficiency Syndromes; Middle Aged; Neutrophil Activation; Oligopeptides; Peptides; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
[Use of myelopid in the complex treatment of patients with destructive pulmonary tuberculosis].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antitubercular Agents; B-Lymphocytes; Humans; Lymphocyte Activation; Middle Aged; Oligopeptides; Peptides; Phagocytosis; Rosette Formation; T-Lymphocytes; Tuberculosis, Pulmonary | 1990 |